Effects of MTBE on the reported incidence of Leydig cell tumors in Sprague-Dawley rats: Range of possible Poly-3 results

Regulatory Toxicology and Pharmacology

Volumn 50, Issue 3, 2008, Pages 273-284

  Goodman, Julie E ^a   Gaylor, David ^b   Beyer, Leslie A ^a   Rhomberg, Lorenz R ^a   Beck, Barbara D ^a  

^a GRADIENT   (United States)

^b Gaylor and Associates LLC   (United States)

Author keywords

Leydig cell tumor; MTBE; Poly 3 analysis; Prevalence analysis; Sprague Dawley rats

Indexed keywords

TERT BUTYL METHYL ETHER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; LEYDIG CELL TUMOR; MALE; MANTEL HAENSZEL TEST; NONHUMAN; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ANIMALS; DATA INTERPRETATION, STATISTICAL; LEYDIG CELL TUMOR; MALE; METHYL ETHERS; MODELS, STATISTICAL; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

ANIMALIA; RATTUS;

EID: 41949091810     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2007.12.005     Document Type: Article

References (38)

1. Agency for Toxic Substances and Disease Registry (ATSDR), 1996. Toxicological Profile for Methyl tert-Butyl Ether. Research Triangle Institute, Research Triangle Park, VA.
2. Bailer A., and Portier C. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44 2 (1988) 417-431
3. Belpoggi F., Soffritti M., and Maltoni C. Methyl-tertiary-butyl ether (MTBE)-a gasoline additive-causes testicular and lymphohaematopoietic cancers in rats. Toxicol. Ind. Health 11 (1995) 119-149
4. Belpoggi F., Soffritti M., Filippini F., and Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl tert-butyl ether. Ann. NY Acad. Sci. 837 (1997) 77-95
5. Belpoggi F., Soffritti M., and Maltoni C. Pathological characterization of testicular tumors and lymphomas-leukaemias, and of their precursors observed in Sprague-Dawley rats exposed to methyl-tertiary-butyl-ether (MTBE). Eur. J. Oncol. 3 (1998) 201-206
6. Bird M.G., Burleigh-Flayer H.D., Chun J.S., Douglas J.F., Kneiss J.J., and Andrews L.S. Oncogenicity studies of inhaled methyl tertiary-butyl ether (MTBE) in CD-1 mice and F-344 rats. J. Appl. Toxicol. 17 (1997) S45-S55
7. Chun J.S., Burleigh-Flayer H.D., and Kintigh W.J. Methyl Tertiary Butyl Ether: Vapor Inhalation Oncogenicity Study in Fischer 344 Rats (1992), Bushy Run Research Center, Export, PA
8. Christensen A.K., and Peacock K.C. Increase in Leydig cell number in testes of adult rats treated chronically with an excess of human chorionic gonadotropin. Biol. Reprod. 22 2 (1980) 383-391
9. Clegg E.D., Cook J.C., Chapin R.E., Foster P.M., and Daston G.P. Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans. Reprod. Toxicol. 22 1 (1997) 107-121
10. Cook J.C., Klinefelter G.R., Hardisty J.F., Sharpe R.M., and Foster P.M.D. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans. Crit. Rev. Toxicol. 29 2 (1999) 169-261
11. Cruzan G., Borghoff S.J., de Peyster A., Hard G.C., McClain M., McGregor D.B., and Thomas M.G. Methyl tertiary -butyl ether mode of action for cancer endpoints in rodents. Regul. Toxicol. Pharmacol. 47 (2007) 156-165
12. Davies T.S., Lynch B.S., Monro A.M., Munro I.C., and Nestmann E.R. Rodent carcinogenicity tests need be no longer than 18 months: an analysis based on 210 chemicals in the IARC monographs. Food Chem. Toxicol. 38 2-3 (2000) 219-235
13. de Peyster A., MacLean K.J., Stephens B.A., Ahern L.D., Westover C.M., and Rozenshteyn D. Subchronic studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer. Toxicol. Sci. 72 1 (2003) 31-42
14. European Centre for Ecotoxicity and Toxicology of Chemicals (ECETOC), 2003. Risk Assessment Report for Existing Substances: Methyl tertiary-Butyl Ether (Special Report No. 17). European Centre for Ecotoxicity and Toxicology of Chemicals, Brussels, 288 p.
15. European Chemicals Bureau (ECB), 2002. European Union Risk Assessment Report: Tert-Butyl Methyl Ether (CAS No: 1634-04-4) (European Chemicals Bureau 3rd Priority list, vol. 19). Office for Official Publications of the EC, Luxembourgh.
16. European Food Safety Authority (EFSA), 2006. Opinion of the scientific panel on food additives, flavourings, processing aids, and materials in contact with food (AFC) on a request from the commission related to a new long-term carcinogenicity study on aspartame. Question number EFSA-Q-2005-122. Eur. Food Saf. Author. J., 356, 1-44. Available from: .
17. Giknis M.L.A., and Clifford C.B. Compilation of Spontaneous Neoplastic Lesions and Survival in CRL:CD (SD) Rats from Control Groups (2004), Charles River Laboratories, Cambridge, MA 28 p.
18. Hard G.C., and Seely J.C. Recommendations for the interpretation of renal tubule proliferative lesions occurring in rat kidneys with advanced chronic progressive nephropathy (CPN). Toxicol. Pathol. 33 6 (2005) 641-649
19. Haseman J.K. A reexamination of false-positive rates for carcinogenesis studies. Fundam. Appl. Toxicol. 3 4 (1983) 334-339
20. Haseman J.K. Commentary on 'Statistical methods for carcinogenicity studies'. Toxicol. Pathol. 30 3 (2002) 405-408
21. Haseman J.K., Arnold J., and Eustis S.L. Tumor incidences in Fischer 344 rats: NTP historical data. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery C.A., and MacKenzie W.F. (Eds). Pathology of the Fischer Rat: Reference and Atlas (1990), Academic Press, San Diego, CA 555-564
22. Hoel D.G., and Walburg H.E. Statistical analysis of survival experiments. J. Nat. Cancer Inst. 49 2 (1972) 361-372
23. Interagency Regulatory Liaison Group (IRLG), 1979. Scientific bases for identification of potential carcinogens and estimation of risks. J. Natl. Cancer Inst., 244 (25)
24. International Agency for Research on Cancer (IARC), 1999. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 73. Some Chemicals that Cause Tumours of the Kidney or Urinary Bladder in Rodents and Some Other Substances (IARC Monograph No. 73). World Health Organization (WHO), Geneva.
25. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 32 (1969) 719-748
26. Maronpot R.R. Who will have the last word?. Toxicol Pathol. 30 3 (2002) 297
27. McGregor D. Methyl tertiary-butyl ether: studies for potential human health hazards. Crit. Rev. Toxicol. 36 4 (2006) 319-358
28. Miller R.A., and Nadon N.L. Principles of animal use for gerontological research. J. Gerontol. A Biolog. Sci. Med. Sci. 55 3 (2000) B117-B123
29. National Toxicology Program (NTP), 2004. Descriptions of NTP Study Types: Expanded Overview. Available from: (accessed 07.07.2006).
30. Peto, R., Pike, M.C., Day, N.E., Gray, R.G., Lee, P.N., Parish, S., Peto, J., Richards, S., Wahrendorf, J., 1980. Guidelines for Simple, Sensitive Significance Tests for Carcinogenic Effects in Long-term Animal Experiments. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Supplement 2, 311-426. International Agency for Research on Cancer (IARC), Lyon, France (1980).
31. Peto Analysis Working Group of STP, 2001. Draft recommendations on classification of rodent neoplasms for Peto analysis. Toxicol. Pathol. 29(2), 265-268.
32. Portier C.J., Hedges J.C., and Hoel D.G. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments. Cancer Res. 46 9 (1986) 4372-4378
33. Prentice D.E., and Meikle A.W. A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat and some comparisons with man. Hum. Exp. Toxicol. 14 (1995) 562-572
34. Robinson M., Bruner R.H., and Olson G.R. Fourteen- and ninety-day oral toxicity studies of methyl tertiary-butyl ether in Sprague-Dawley rats. J. Am. Coll. Toxicol. 9 5 (1990) 525-540
35. Soffritti M., Belpoggi F., Minardi F., and Maltoni C. Ramazzini Foundation cancer program: history and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results. Ann. NY Acad. Sci. 98 2 (2002) 26-45
36. US Environmental Protection Agency (US EPA), 1997. Drinking Water Advisory: Consumer Acceptability Advice and Health Effects Analysis on Methyl tertiary-Butyl Ether (MtBE) (EPA-822-F-97-009). Office of Water, Washington, DC.
37. US Food and Drug Administration (US FDA), Center for Drug Evaluation and Research, 2001. Guidance for Industry: Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals. Available from: (accessed 18.11.2006).
38. Williams T.M., Cattley R.C., and Borghoff S.J. Alterations in endocrine responses in male Sprague-Dawley rats following oral administration of methyl tert-butyl ether. Toxicol. Sci. 54 (2000) 168-176